| V |
|
Validation of the first hemophilia-specific quality of life questionnaire for children and adolescents (Hemo-QoL)
|
| Mackensen V. S., Bullinger M., Hemo-Qol Investigators Group‡ |
| |
|
Validation of the Taipan snake venom assay in routine practice to assess lupus anticoagulant status in patients being assessed for lupus anticoagulant and not receiving oral anticoagulant
|
| Parmar K., Connor P., Hughes G. R. V., Hunt B. J. |
| |
|
Variability in antifactor Xa assay procedures
|
| Koerber J. M., Mattson J. C., Smythe M. A. |
| |
|
Variability in factor VIII concentrate measurement: results from SSC Field Collaborative Studies
|
| Raut S., Sands D., Heath A. B., Barrowcliffe T. W. |
| |
|
Variability of clinical laboratory practice in testing for disorders of platelet function: results of a NASCOLA survey
|
| Moffat K. A., Ledford M. R., Nichols W. L., Hayward C. P. M. |
| |
|
Variant Creutzfeldt–Jakob disease and its transmission by blood
|
| Ironside J. W., Head M. W. |
| |
|
Variants of rFVlla with increased intrinsic activity
|
| Persson E. |
| |
|
Variation in antithrombin helix A impedes secretion and function of the inhibitor
|
| Cawston E., Fitches A. C., Olds R. J. |
| |
|
Variation in plasminogen activator inhibitor-1 gene and risk of meningococcal disease
|
| Geishofer G., Zenz W., Moritz M., Müller W., Walcher W., Endler G., Häring D., Faber J., Finn A., Mannhalter CH. |
| |
|
Variation of GPVI levels in platelets: relationship to platelet function at high shear
|
| Best D., Senis Y. A., Jarvis G. E., Saito T., Jung S. M., Moroi M., Harrison P., Green F. R., Watson S. P. |
| |
|
Variations of INR and Factor VII Level are linked to Cytochrome P450 2C9 genotype
|
| Robert A., Morin S., Loriot M.-A, Thijssen H. H. W., Verstuyft C., Strabach S., Dubert L., Funck-Brentano C., Jaillon P., Beaune P. H., Becquemont L. |
| |
|
Various ratio of n-3/n-6 polyunsaturated fatty acid alters the tendency of thrombosis and progress of atherosclerosis in apoE-/- LDLR-/- double knockout mouse
|
| Yamashita T., Oda E., Sano T., Yamashita T, Ijiri Y., Yamamoto J. |
| |
|
Vascular bed specific hemostasis
|
| Aird W. C. |
| |
|
Vascular biology - the role of tissue factor
|
| Hathcock J. |
| |
|
VCAM-1/VLA-4 up-regulation as a perpetuation loop in patients with chronic graft vs. host disease?
|
| Tsakiris D. A., Gratwohl A., Heim D., Marbet G. A., Biedermann B. C. |
| |
|
Vena cava filters in children: review of a single centre clinical experience over 7 years
|
| Williams S., Chait P., Temple M., Connolly B., Chan A. K., Bauman M., Ashe M., Massicotte M. P. |
| |
|
Vena Tech Vena Caval filters – a 7-year single institution experience and review of the literature
|
| Tran H. A. |
| |
|
Venice DVT
|
| Parisi R., Bortoluzzi C., Contavalli C., Doria S., Leprotti C., Ramuscello S., Slongo C., Ambrosio G. B. |
| |
|
Venous and arterial thromboembolic risk in first degree family members of patients with elevated plasma levels of clotting factor VIII:c
|
| Bank I., Libourel E. J., Middledorp S., Hamulyak K., Van Der Meer J., Koopman M. M. W., Van Pampus E. C. M., Prins M. H., Buller H. R. |
| |
|
Venous outflow resistance can be used after acute deep-vein thrombosis as a screening test to identify patients at risk of the post-trombotic syndrome
|
| Roumen-Klappe E., Den Heijer M., Holewijn S., Wollersheim H. |
| |
|
Venous thromboembolic complications in patients with multiple myeloma treated with thalidomide:prophylatic effect of fixed dose Wafarin L
|
| Valdre L., Cini M., Legnani C., Zamagni E., Cosmi B., Cellini C., Cavo M., Palareti G. |
| |
|
Venous thromboembolism (VTE) associated with the management of acute thrombotic thrombocytopenic purpura (TTP)
|
| Yarranton H., Cohen H. C., Machin S. J. |
| |
|
Venous thromboembolism (VTE) in children: A prospective 10-year registry in Argentina
|
| Bonduel M., Hepner M., Sciuccati G., Pieroni G., Feliu Torres A., Frontroth J., Serviddio M. R. |
| |
|
Venous thromboembolism (VTE) in children: a series of cases from a pediatric Brazilian cohort
|
| Carneiro J., Matsumoto L. A., Odone-Filho V., Vargas R. N., Chamone D. A. F., D'Amico E. A. |
| |
|
Venous thromboembolism and fractured neck or femur
|
| Fletcher J., Hitos K. |
| |
|
Venous thromboembolism and the -455G/Ab-fibrinogen gene polymorphism
|
| Camilleri R., Cohen H. |
| |
|
Venous thromboembolism during pregnancy and postpartum: results from a prospective cohort of women treated according to a risk score
|
| Chauleur C., Varlet M. N. |
| |
|
Venous thromboembolism in North-western Russia and genetic polymorphisms
|
| Shmeleva V. M., Kapustin S. I., Filanovskaya L. I., Blinov M. N. |
| |
|
Venous thrombo-embolism in the black population
|
| Patel R., Bonner L., Lambie J., Arya R. |
| |
|
Venous thromboembolism is common but does not alter survival in glioblastoma multiforme
|
| Shet A. S., Schorer A. E., Kuskowski M. |
| |
|
Venous thrombosis and APC resistance during hormone treatment in male-to-female transsexuals
|
| Thomassen M. C. L. G. D., Toorians A. W. F. T., Magdeleijns E. J. P., Beukenkamp H., Tans G., Zweegman S., Rosing J., Gooren L. J. G. |
| |
|
Venous thrombosis in cancer patients: insights from the FRONTLINE survey
|
| Kakkar A., Levine M. N., Pinedo H. M., Wolff R., Wong J. |
| |
|
Venous thrombosis in children
|
| Chan A. K., Deveber G., Monagle P., Brooker L. A., Massicotte P. M. |
| |
|
Very low dose warfarin for primary and secondary prophylaxis in children: a prospective cohort study of 20 children
|
| Bauman M., Mitchell L., Chan A. K., de Veber G., Massicotte M. P. |
| |
|
Vipera lebetina factor X activating enzyme – cloning and sequencing
|
| Siigur E., Aaspollu A., Trummal K., Tammiste I., Siigur J. |
| |
|
Virtual decrease of von Willebrand Factor-cleaving protease (ADAMTS13) after infusion of desmopressin (DDAVP)
|
| Farías C., Kempfer A. C., Amaral M. M., Woods A. I., Nadal M. V., Carballo G. A., Meschengieser S. S., Lazzari M. A. |
| |
|
Virus validation studies utilizing model viruses are relevant for west Nile virus
|
| Gröner A., Nowak T., Schäfer W. |
| |
|
Visceral vein thrombosis: retrospective analysis of 53 cases in five Italian thrombosis
|
| Ghirarduzzi A., Scannapieco G., Imberti D., Barcellona D., Marongiu F., Taliani M. R., Agnelli G. |
| |
|
Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal transplant recipients
|
| Marcucci R., Zanazzi M., Bertoni E., Salvadori M., Castellani S., Fedi S., Gensini F., Giusti B., Pepe G., Prisco D., Abbate R., Gensini G. F. |
| |
|
Von Willebrand disease: a bleeding disorder increasingly recognized over the recent years
|
| Platokouki H., Avgeri M., Pergantou H., Adamtziki E., Aronis S. |
| |
|
Von Willebrand factor cleaving protease (VWFCP) activity in patients with pre-eclampsia history: preliminary results
|
| Amaral M., Sánchez Luceros A., Farías C., Carballo G. A., Kempfer A. C., Lazzari M. A. |
| |
|
Von Willebrand factor measurement in the UK NEQAS proficiency testing program
|
| Jennings I., Kitchen S., Kitchen D., Woods T. A. L., Preston F. E. |
| |
|
Von Willebrand factor, platelets and endothelial cell interactions
|
| Ruggeri Z. M. |
| |
|
VWF/FVIII concentrate enhances platelet adhesion onto a surface of immobilized collagen under flow conditions
|
| Kamikubo Y., Tomokiyo K., Hanada T., Araki T., Nakatomi Y., Ogata Y., Jung S. M., Nakagaki T., Moroi M. |
| |
|
VWF:RCo assay implementation on automated coagulometer
|
| Redaelli R., Borroni L., Mostarda G., Corno A. R., Morra E., Baudo F. |
| |
